SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-14-000329
Filing Date
2014-11-17
Accepted
2014-11-17 14:21:04
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 f10qsept302014vedgar2.htm 10-Q 384219
3 exhibit311.htm EX-31 17208
4 exhibit312.htm EX-31 16553
5 exhibit321.htm EX-32 8216
6 exhibit322.htm EX-32 8940
  Complete submission text file 0001551163-14-000329.txt   948075

Data Files

Seq Description Document Type Size
7 prtt-20140930.xml EX-101.INS 27918
8 prtt-20140930.xsd EX-101.SCH 10463
9 prtt-20140930_cal.xml EX-101.CAL 11767
10 prtt-20140930_def.xml EX-101.DEF 7569
11 prtt-20140930_lab.xml EX-101.LAB 50783
12 prtt-20140930_pre.xml EX-101.PRE 43189
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 141227396
SIC: 2834 Pharmaceutical Preparations